Liver Function Test 2

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

brain degeneration >20mg/dl

KERNICTERUS

WHAT BILIRUBIN increased affinity in brain

BILIRUBIN 1

KERNICTERUS mg/dl

>20 mg/dl

treatment for kernicterus

PHOTOTHERAPY/UV

THIS TREATMENT DESTROYS BILIRUBIN

PHOTO THERAPY/UV

- Bilirubin excretion deficit

Dubin-Johnson

Dubin-Johnson - WHAT deficit

Bilirubin excretion

obstructive in nature i. Delta bilirubin is seen

Dubin-Johnson

WHAT IS SEEN IN Dubin-Johnson

Delta bilirubin

SAMPLE FOR THE OBSERVATION OF LIPOFUCHSIN

LIVER BIOPSY

PIGMENT USED IN LIVER BIOPSY

LIPOFUCHSIN

Dubin-Johnson LIKE AND NEGATIVE PIGMENT

Rotor

- circulating INHIBITOR of bilirubin conjugation

Lucey Driscoll

Delta bilirubin is COMBINATION OF?

B2+ALBUMIN

B2+ALBUMIN SEEN IN POST HEPATIC

Delta bilirubin

B2 ACCUMULATION WHICH CREATES PIGMENT

Dubin-Johnson

B2 ACCUMULATION WHICH DOESNT CREATE PIGMENT

Rotor

INCREASED/DECREASED/NORMAL 1. B1 2. B2 3. URINARY UROBILINOGEN HEMOLYTIC DISEASE

(INCREASED HIGHEST) INCREASED NORMAL INCREASED

INCREASED/DECREASED/NORMAL 1. B1 2. B2 3. URINARY UROBILINOGEN EARLY LIVER DISEASE

INCREASED INCREASED DECREASED

INCREASED/DECREASED/NORMAL 1. B1 2. B2 3. URINARY UROBILINOGEN LATE LIVER DISEASE

INCREASED INCREASED INCREASED

INCREASED/LOW/NORMAL 1. B1 2. B2 CN

INCREASE LOW

INCREASED/DECREASED/NORMAL 1. B1 2. B2 GILBERT

INCREASED NORMAL

INCREASED/DECREASED/NORMAL 1. B1 2. B2 DJ AND ROTOR

NORMAL INCREASED

INCREASED/DECREASED/NORMAL 1. B1 2. B2 NEWBORN JAUNDICE

INCREASED NORMAL

INCREASED/DECREASED/NORMAL 1. B1 2. B2 3. URINARY UROBILINOGEN BILE DUCT OBSTRUCTION

INCREASED INCREASED DECREASED

PARTIAL OBSTRUCTION STOOL COLOR

PALE YELLOW STOOL

COMPLETE OBSTRUCTION STOOL COLOR

GRAY

not noticeable to the eye

Overt jaundice

YELLOW EYE, SKIN, MUCUS MEMBRANE

Jaundice

Jaundice AKA

JAUNE OR YELLOW

Called icterus or hyperbilirubinemia.

Jaundice

Jaundice Called

icterus or hyperbilirubinemia.

BILIBURIN Evident: bilirubin level exceeds

3-5 MG/DL

The clinical manifestation of jaundice develops when total bilirubin levels exceed:

3mg/dL or 51.3 umol/L

BILIBURIN Methods c. Hemolysis – ? reaction

decrease reaction

BILIBURIN Methods c. ? – decrease reaction

Hemolysis

BILIBURIN Methods – false increase

Lipemia

BILIBURIN Methods Lipemia –

false increase

BILIBURIN Methods SHOULD BE TESTED WITHIN? IN WHAT PLACE?

2-3 HOURS, DARK PLACE

BILIBURIN Room temp FOR HOW MANY DAYS?

2 days

SAMPLE IN BILIBURIN WHEN KEEP IN 4 DEGREES C IS UP TO?

1 week

SAMPLE IN BILIBURIN WHEN KEEP IN .-20oC IS UP TO?

Indefinite

SAMPLE IN BILIBURIN 1 week STORAGE IS KEEP IN

4oC

SAMPLE IN BILIBURIN Indefinite STORAGE IS KEEP IN

-20oC

BILIBURIN Visible icterisia:

>25mg/dl

BILIBURIN reagent

Diazo reagent

no need for accelerant

= reacts slowly = need accelerants

- pink to purple azobilirubi

Evelyn and Malloy Method

Evelyn and Malloy Method -

pink to purple azobilirubin

Evelyn and Malloy Method Accelerant:

Methanol

.reaction at pH 1.2 with maximal absorbance at 560nm

Evelyn and Malloy Method

Evelyn and Malloy Method reaction at pH ? with maximal absorbance at NM?

1.2 560nm

- pink to blue azobilirubin

Jendrassik and Grof

Jendrassik and Grof -

pink to blue azobilirubin

Jendrassik and Grof Accelerant:

Caffeine sodium benzoate

More sensitive than Evelyn and Malloy Not affected by Hb and pH changes Vit C. Terminates the reaction and destroy diazo

Jendrassik and Grof

Terminates the reaction and destroy diazo

Vit C.

Not affected by Hb and pH changes

Jendrassik and Grof

FORMULA OF B1

B1=TB-DB

bilirubin Method only for neonates

Bilirubinometer

Principle: reflectance photomotery on skin

Bilirubinometer

NON PROTEIN NITROGEN: LIVER DETOXIFICATION

AMMONIA

AMMONIA DETOXIFICATION OF?

LIVER

From deamination of amino acids

AMMONIA

AMMONIA Severe liver disease

Hepatic Coma (NH3 is neurotoxic) and Encephalopathy

AMMONIA USES ASPIRIN INGESTION

REYE'S SYNDROME

REYE'S SYNDROME INGESTION

ASPIRIN

Monitor hyper alimentation therapy

AMMONIA

eating in a tube

hyper alimentation therapy

Neonate UREA cycle defect

AMMONIA

ANTI PAIN/ POSION

Acetaminophen/ TYLENOL

INCREASED BUN; DECREASED NH3

SEVERE LIVER DISEASE

WHAT DECREASES WHEN THERE IS HEPATIC COMA?

GABA-GAMMA AMINO BUTYRIC ACID

FALSE ELEVATION/FALSE LOW prolonged specimen

FALSE ELEVATION

FALSE ELEVATION/FALSE LOW hemolyzed sample

FALSE ELEVATION

FALSE ELEVATION/FALSE LOW Diphenhydramine

FALSE LOW

FALSE ELEVATION/FALSE LOW Lactobacillus acidophilus

FALSE LOW

ARE ACID PRODUCERS + NH3 (BASE)

Diphenhydramine Lactobacillus acidophilus

Glucose at concentrations > ______________mg/dL (33 mmol/L) interferes in dry slide methods

600

Glucose at concentrations > 600mg/dL (?) interferes in dry slide methods

33 mmol/L

AMMONIA BLOOD Specimen

arterial blood

AMMONIA PREFERRED TUBE

Heparin/EDTA

AMMONIA Specimen TO SLOW down deamination

.ice water

Plasma stable up to ? in ice bath; stable several days frozen

3 1/2 hr

NH3 in Microdiffusion chamber-> NH3 gas + Sol’n w/pH indicator-> Measured using Titration

CONWAY

Methods AMMONIA –The most common technique

Glutamate dehydrogenase (GLDH)

Methods AMMONIA Direct measurement NH3 thru the ISM -> NH3 + Ammonium chloride -> Change in pH

Potentiometry (Ion selective electrode)

REVERSE REACTION AKA?

WROBLEUSKI METHOD

WROBLEUSKI METHOD AKA

REVERSE REACTION

WROBLEUSKI METHOD AKA REVERSE REACTION

NADH->NAD DECREASED ABS. 340NM INVERSELY PROPORTIONAL TO INCREASED CONCENTRATION

WACKER METHOD AKA

FOWARD METHOD

FOWARD METHOD AKA

WACKER METHOD

WACKER METHOD AKA FOWARD METHOD

NAD->NADH INCREASED ABS. 340NM DIRETCLY PROPORTIONAL TO INCREASED CONCENTRATION

AMMONIA

Berthelot reaction and Nesslerization reaction

AMMONIA

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前